14.07.2014 - AbbVie Inc. plans to expand business

Company Shire PLC has received a new offer to buy shares of the company from AbbVie Inc. Shire PLC specializes in manufacturing of drugs to treat attention deficit and rare diseases. Final bid was 4% better than the previous. So that for one company's stock offer 53.20 British pounds.

Under the agreed terms of deal shareholders will receive 24.44 pounds per share plus 0.8960 shares AbbVie Inc. And will own 25% of the combined group. Merging capital leads to positive effects and will probably positively influence the quotes of AbbVie Inc. in the medium term. Until the end of the, quotations may grow by 8-9%.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.